FR2817869B1 - MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF - Google Patents

MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF

Info

Publication number
FR2817869B1
FR2817869B1 FR0015926A FR0015926A FR2817869B1 FR 2817869 B1 FR2817869 B1 FR 2817869B1 FR 0015926 A FR0015926 A FR 0015926A FR 0015926 A FR0015926 A FR 0015926A FR 2817869 B1 FR2817869 B1 FR 2817869B1
Authority
FR
France
Prior art keywords
fragment
influenza virus
human antibody
directed against
antibody directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0015926A
Other languages
French (fr)
Other versions
FR2817869A1 (en
Inventor
Jacques Noury
Herve Bazin
Dominique Latinne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technopharm SARL
Original Assignee
Technopharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technopharm SARL filed Critical Technopharm SARL
Priority to FR0015926A priority Critical patent/FR2817869B1/en
Priority to PCT/FR2001/003883 priority patent/WO2002046235A1/en
Priority to AU2002217213A priority patent/AU2002217213A1/en
Publication of FR2817869A1 publication Critical patent/FR2817869A1/en
Application granted granted Critical
Publication of FR2817869B1 publication Critical patent/FR2817869B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
FR0015926A 2000-12-07 2000-12-07 MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF Expired - Fee Related FR2817869B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0015926A FR2817869B1 (en) 2000-12-07 2000-12-07 MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF
PCT/FR2001/003883 WO2002046235A1 (en) 2000-12-07 2001-12-07 Human monoclonal antibody directed against the influenza virus or a fragment thereof
AU2002217213A AU2002217213A1 (en) 2000-12-07 2001-12-07 Human monoclonal antibody directed against the influenza virus or a fragment thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0015926A FR2817869B1 (en) 2000-12-07 2000-12-07 MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF

Publications (2)

Publication Number Publication Date
FR2817869A1 FR2817869A1 (en) 2002-06-14
FR2817869B1 true FR2817869B1 (en) 2005-01-14

Family

ID=8857376

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0015926A Expired - Fee Related FR2817869B1 (en) 2000-12-07 2000-12-07 MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF

Country Status (3)

Country Link
AU (1) AU2002217213A1 (en)
FR (1) FR2817869B1 (en)
WO (1) WO2002046235A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0522460D0 (en) * 2005-11-03 2005-12-14 Prendergast Patrick T Composition and method for the treatment of avian influenza
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
AU2007249160B2 (en) * 2006-05-15 2013-09-12 I2 Pharmaceuticals, Inc. Neutralizing antibodies to influenza viruses
ITTO20070066A1 (en) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMOTOPI ANTIGENE GP 120 DI HIV
CN102046654A (en) 2007-03-13 2011-05-04 胡马斯有限公司 Antibodies against H5N1 strains of influenza a virus
EP3524619A1 (en) 2007-12-06 2019-08-14 Dana-Farber Cancer Institute, Inc. Antibodies against influenza virus and methods of use thereof
ITTO20080204A1 (en) * 2008-03-17 2009-09-18 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES ACTIONS TO REACT WITH A PLURALITY OF SUBTIPS OF THE INFLUENTIAL VIRUS A
ITTO20080398A1 (en) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES HAVING PROPERTY OF HOSUBLICTIC CROSS-NEUTRALIZATION FOR INFLUENTIAL VIRUSES OF SUBTIPLE TYPE H1
ITTO20080964A1 (en) 2008-12-22 2010-06-23 Natimab Therapeutics S R L ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICATION FOR THERAPEUTIC TREATMENT AND THE PREVENTION OF HCV INFECTIONS
IT1395961B1 (en) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES AS A MEDICATION FOR THERAPEUTIC AND / OR PROFILACTIC TREATMENT OF INFLUENCIAL VIRUS INFECTIONS (H1N1) OF SWINE ORIGIN (S-OIV)
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
CN104968367B (en) 2012-11-13 2018-04-13 弗·哈夫曼-拉罗切有限公司 Antihemagglutinin antibody and application method
IL241552B2 (en) 2013-03-14 2023-09-01 Contrafect Corp Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN113924147A (en) 2019-03-25 2022-01-11 威特拉公司 Compositions and methods for treating and preventing influenza

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH668775A5 (en) * 1983-07-08 1989-01-31 Sandoz Ag Highly stable hybridomaoma cell line for antibody prodn. - made by fusing secreting cell with compatible xenogeneic hybrid as immortalising component
JP2518607B2 (en) * 1985-08-29 1996-07-24 雪印乳業株式会社 Monoclonal antibody against influenza A virus HA antigen and method for producing the same
CA2002067A1 (en) * 1988-11-09 1990-05-09 Tamotsu Fukuda Parent cell line for producing human hybridomas

Also Published As

Publication number Publication date
AU2002217213A1 (en) 2002-06-18
WO2002046235A1 (en) 2002-06-13
FR2817869A1 (en) 2002-06-14

Similar Documents

Publication Publication Date Title
FR10C0050I2 (en) OPGL ANTIBODIES
DZ3095A1 (en) Acoustic detector assembly.
FR2817869B1 (en) MONOCLONAL HUMAN ANTIBODY DIRECTED AGAINST INFLUENZA VIRUS OR A FRAGMENT THEREOF
NO20026121D0 (en) streptococcal Antigens
HUP0500444A3 (en) Hcv antigen/antibody combination assay
IS2620B (en) Human antibodies that detect beta-amyloid peptides
CY2011008I2 (en) FLU VACCINE
DE50104720D1 (en) Deodorising preparations
NL1015859A1 (en) Pharmaceutical preparations.
HK1096975A1 (en) Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody
ID29577A (en) PESTICIDE PROTEIN
NO20030239D0 (en) Modified virus
BR0108414B1 (en) use of a material and conduit.
DK1164375T3 (en) Assay for antitransglutaminase antibodies
NO20021604L (en) Leptin assay
FR2806525B1 (en) STARTER ASSEMBLY
FR2827938B1 (en) WALL CROSSING ASSEMBLY
MA27184A1 (en) ANTI-INGAP ANTIBODY ASSAY
DE60030601D1 (en) APPAREIL DE POLISSAGE CHIMICO-MECANIQUE
FR2818508B1 (en) SHAVING SET
DE60111415D1 (en) NAIL SCHNEIDER
FR2797621B1 (en) CONTAINER ASSEMBLY
DK200000305U3 (en) ultrasonic
AR028262A1 (en) HUMAN FAP-ALFA SPECIFIC ANTIBODIES
FR2811796B1 (en) SECURE PORTABLE ASSEMBLY

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060831